ctrl K

Watchlist Price Alert

Roivant Sciences Ltd. (ROIV)

NASDAQ: ROIV · Real-Time Price · USD

11.19

-0.01 (-0.09%)

At close: Jun 06, 2025, 1:56 PM

Roivant Sciences Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	124.8M	61.28M	55.29M	23.8M	67.69M
Cost of Revenue	27.96M	13.13M	8.97M	2.06M	1.13M
Gross Profit	96.83M	48.15M	46.32M	21.74M	66.56M
Operating Income	4.24B	-1.18B	-1.35B	-1.07B	-532.42M
Interest Income	146.43M	32.18M	369K	1.42M	17.99M
Pretax Income	4.25B	-1.22B	-923.75M	-898.55M	-560.99M
Net Income	4.35B	-1.01B	-845.26M	-809.23M	1.2B
Selling & General & Admin	675.04M	600.51M	775.03M	259.88M	335.77M
Research & Development	501.74M	525.22M	483.04M	236.63M	263.22M
Other Expenses	-5.32B	97.75M	139.89M	596.13M	n/a
Operating Expenses	-4.13B	1.22B	1.4B	1.09B	598.98M
Interest Expense	34.78M	27.97M	7.04M	2.81M	7.68M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-4.12B	1.24B	1.41B	1.09B	600.11M
Income Tax Expense	22.22M	5.19M	369K	1.69M	7.12M
Shares Outstanding (Basic)	783.25M	712.79M	669.75M	684.79M	215.35M
Shares Outstanding (Diluted)	831.05M	712.79M	669.75M	684.79M	215.35M
EPS (Basic)	5.55	-1.42	-1.26	-1.18	5.21
EPS (Diluted)	5.23	-1.42	-1.26	-1.18	5.21
EBITDA	4.31B	-1.18B	-916.71M	-895.74M	-553.3M
EBIT	4.29B	-1.2B	-916.71M	-895.74M	-553.3M
Depreciation & Amortization	22.04M	18.86M	5.93M	175.16M	-20.88M